Skip to Content

The Cigna Group CI

Morningstar Rating
$343.28 −3.14 (0.91%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

CI is trading at a 517% premium.
Price
$346.42
Fair Value
$929.00
Uncertainty
Medium
1-Star Price
$573.40
5-Star Price
$299.40
Economic Moat
Qvxwrp
Capital Allocation
Ztztkhsd

Bulls Say, Bears Say

Bulls

Combining with Express Scripts gave Cigna more tools to help clients control their healthcare costs, and we see significant cross-selling opportunities across their respective books of business.

Bears

Healthcare reform may remain a recurring political topic until universal, affordable coverage is achieved in the US, and Cigna's stock may experience volatility if scenarios that threaten its prospects gain traction.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CI is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$346.42
Day Range
$342.08345.62
52-Week Range
$240.50365.71
Bid/Ask
$339.04 / $347.65
Market Cap
$97.52 Bil
Volume/Avg
2.2 Mil / 1.5 Mil

Key Statistics

Price/Earnings (Normalized)
13.24
Price/Sales
0.50
Dividend Yield (Trailing)
1.46%
Dividend Yield (Forward)
1.60%
Total Yield
6.51%

Company Profile

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.
Sector
Healthcare
Industry
Healthcare Plans
Stock Style Box
Large Value
Total Number of Employees
72,500

Competitors

Valuation

Metric
CI
CVS
HUM
Price/Earnings (Normalized)
13.247.1314.45
Price/Book Value
2.390.952.57
Price/Sales
0.500.200.39
Price/Cash Flow
11.835.9012.36
Price/Earnings
CI
CVS
HUM

Financial Strength

Metric
CI
CVS
HUM
Quick Ratio
0.54
Current Ratio
0.81
Interest Coverage
4.814.557.86
Quick Ratio
CI
CVS
HUM

Profitability

Metric
CI
CVS
HUM
Return on Assets (Normalized)
5.11%4.07%5.46%
Return on Equity (Normalized)
17.27%13.68%17.15%
Return on Invested Capital (Normalized)
10.86%7.90%11.21%
Return on Assets
CI
CVS
HUM
See how this stock stacks up to its competitors with Morningstar Investor

Healthcare Plans Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
UNH
UnitedHealth Group IncLtxrpshphJkxxllw$471.0 Bil
ELV
Elevance Health IncJrydfxxdYyjkbxz$124.3 Bil
CVS
CVS Health CorpHvtltttnBynbgp$70.3 Bil
CNC
Centene CorpZkgxmyxhfRwfsyx$41.0 Bil
HUM
Humana IncHfnycczfLswnkd$40.9 Bil
MOH
Molina Healthcare IncDzszkct$20.5 Bil
OSCR
Oscar Health Inc Class AJlwzp$5.4 Bil
ALHC
Alignment Healthcare IncDblt$1.3 Bil
CLOV
Clover Health Investments Corp Ordinary Shares - Class ACnws$506.4 Mil

Sponsor Center